GENENTECH, INC for GENENTECH INC
What was lobbied
8 issue areas, each in the filer's own words, with who lobbied on it and where.
Trade (domestic/foreign) TRD
Trade Policy Issues. Trade Negotiations.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DAVID B BURT | — |
| CATHERINE LYTTON PHILLIPS | — |
| ANDREW WESLEY WOMACK | — |
Medical/Disease Research/Clinical Labs MED
Issues related to Right to Try
| Lobbyist | Covered position, as disclosed |
|---|---|
| DAVID B BURT | — |
| ANDREW WESLEY WOMACK | — |
Taxation/Internal Revenue Code TAX
H.R.1, Tax Reform Act of 2017 (Public Law No. 115-97) Issues related to the tax reform bill and implementation
| Lobbyist | Covered position, as disclosed |
|---|---|
| DAVID B BURT | — |
| CATHERINE LYTTON PHILLIPS | — |
| MATTHEW L SULKALA | — |
Health Issues HCR
H.R. 4710 - 340B Protecting Access for the Underserved and Safety-Net Entities Act. S. 2312 - The Helping Ensure Low-income Patients have Access to Care and Treatment Act S. 2453 - Ensuring the Value of the 340B Program Act of 2018 S.204/H.R.878, Trickett Wendler Right to Try Act of 2017. P.L.109-417, Pandemic and All-Hazards Preparedness Act (PAHPA). Policies relating to the 340B Drug Discount Program Development of Policies to advance antimicrobial research and novel product development environment, including advancing new market incentives. Issues and policies relating to the Food and Drug Administration including biopharmaceutical development, drug safety and counterfeiting, and biosimilars. General education about policies impacting pharmaceutical development, approval, reimbursement and pricing.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DAVID B BURT | — |
| ELISE MARIE CONNER | — |
| CATHERINE LYTTON PHILLIPS | — |
| MATTHEW L SULKALA | — |
| ANDREW WESLEY WOMACK | — |
Copyright/Patent/Trademark CPT
Intellectual property and process patent issues. General IP issues. Patent litigation reform.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DAVID B BURT | — |
| CATHERINE LYTTON PHILLIPS | — |
Medicare/Medicaid MMM
H.R. 4710 - 340B Protecting Access for the Underserved and Safety-Net Entities Act. S. 2312 - The Helping Ensure Low-income Patients have Access to Care and Treatment Act S. 2453 - Ensuring the Value of the 340B Program Act of 2018 Part D Medicare Program (including Coverage Gap and other offsets in H.R.1892/P.L.115-123, Bipartisan Budget Act of 2018). Issues related to Medicare and Medicaid coverage and reimbursement Issues related to the 340B Drug Discount Program Issues related to RX drug pricing Medicare reimbursement for biosimilars MACRA treatment and reimbursement of Part B drugs Medicare payments for inpatient antimicrobials
| Lobbyist | Covered position, as disclosed |
|---|---|
| DAVID B BURT | — |
| ELISE MARIE CONNER | — |
| CATHERINE LYTTON PHILLIPS | — |
| MATTHEW L SULKALA | — |
| ANDREW WESLEY WOMACK | — |
Budget/Appropriations BUD
H.R.3358/S.1771, Departments of Labor, Health, and Human Services, and Education, and Related Agencies Appropriations Act, 2018 H.R.3268/S.1603, Agriculture, Rural Development, Food, and Drug Administration, and Related Agencies Appropriations Act, 2018 H.R.1370, Further Additional Continuing Appropriations Act, 2018 H.R.1892, Bipartisan Budget Act of 2018 H.R.1625, Consolidated Appropriations Act, 2018 Issues related to FDA and HHS program funding for the FY18 Labor, Health and Human Services, and Education and Related Agencies, and FY18 Agriculture, Rural Developments, Food, and Drug Administrations, and Related Agencies Appropriation bills Issues related to FDA and HHS program funding for the FY19 Labor, Health and Human Services, and Education and Related Agencies, and FY18 Agriculture, Rural Developments, Food, and Drug Administrations, and Related Agencies Appropriation bills
| Lobbyist | Covered position, as disclosed |
|---|---|
| DAVID B BURT | — |
| ELISE MARIE CONNER | — |
| CATHERINE LYTTON PHILLIPS | — |
| MATTHEW L SULKALA | — |
| ANDREW WESLEY WOMACK | — |
Pharmacy PHA
Drug Pricing Issues Prescription Drug User Fee Act reauthorization. HR 4710, 340B Pause Act and other issues relating to the 340B Drug Discount Program
| Lobbyist | Covered position, as disclosed |
|---|---|
| DAVID B BURT | — |
| ELISE MARIE CONNER | — |
| CATHERINE LYTTON PHILLIPS | — |
| MATTHEW L SULKALA | — |
| ANDREW WESLEY WOMACK | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.